Cambridge Investment Research Advisors’s AllianzIM U.S. Equity Buffer10 Aug ETF AUGT Stock Holding History
Bought
Maintained
Sold
Other funds holding AUGT
SB
KAS
OMC
HI
Cambridge Investment Research Advisors's AUGT Position: Q1 2026 in Review
Cambridge Investment Research Advisors increased its AllianzIM U.S. Equity Buffer10 Aug ETF (AUGT) stake by 11% in Q1 2026, buying an estimated $29.7K and bringing the position to 8,153 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #3332.
Cambridge Investment Research Advisors first reported a position in AUGT in Q4 2023 and has held it in 6 quarters since. The position peaked at $334K in Q1 2024. 27 funds tracked by Wall St. Rank hold AUGT as of Q1 2026.
- Cambridge Investment Research Advisors held 8,153 shares of AllianzIM U.S. Equity Buffer10 Aug ETF worth $284K as of Q1 2026.
- Cambridge Investment Research Advisors bought 834 AllianzIM U.S. Equity Buffer10 Aug ETF shares in Q1 2026, an estimated $29.7K.
- AllianzIM U.S. Equity Buffer10 Aug ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #3332 holding.
- Cambridge Investment Research Advisors first reported a position in AllianzIM U.S. Equity Buffer10 Aug ETF in Q4 2023 and has held it in 6 quarters since.
- Cambridge Investment Research Advisors's AllianzIM U.S. Equity Buffer10 Aug ETF position peaked at $334K in Q1 2024.
- 27 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Aug ETF as of Q1 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.